Skip to main content

Lurker Nancy

In the past year, 3 open-market sale filings worth $312.9K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$312.9K
3 filings
Net
−$312.9K
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists Lurker Nancy as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

COLL Collegium Pharmaceutical, Inc

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 15, 2026 (view filing)May 132 daysLurker NancyDirectorSSale−4.50K$35.97−$161.9K−20.0%18.0K after

EYPT EyePoint, Inc.

Director6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 5, 2025 (view filing)Dec 41 dayLurker NancyDirectorSSale−9.30K$15.11−$140.5K−4.3%206.5K after10b5-1
Dec 1, 2025 (view filing)Nov 26-285 daysLurker NancyDirectorSSale−700$14.95−$10.5K−0.3%215.8K after2 lots10b5-1
Aug 20, 2024 (view filing)Aug 164 daysLurker NancyDirectorPPurchase+3.17K$7.88+$25.0K+3.4%97.6K after
Jan 25, 2024 (view filing)Jan 23-242 daysLurker NancyExecutive Vice ChairSSale−35.0K$24.98−$874.2K−20.5%135.4K after2 lots10b5-1
Dec 6, 2023 (view filing)Dec 42 daysLurker NancyExecutive Vice ChairSSale−20.0K$20.76−$415.2K−10.5%170.6K after10b5-1
Nov 17, 2021 (view filing)Nov 152 daysLurker NancyPresident & CEOSSale−10.0K$20.15−$201.5K−8.8%103.5K after